INRETS, LBMC UMRT 9406, Lyon 1 University, Lyon-Sud Hospital, 69495 Pierre-Bénite cedex, France.
Orthop Traumatol Surg Res. 2010 May;96(3):291-303. doi: 10.1016/j.otsr.2010.03.002. Epub 2010 Apr 15.
After more than 10 years' experience in France, the French Foot Surgery Association (Association française de chirurgie du pied [AFCP]) presents an update on mobile-bearing ankle prostheses, based on a multicenter study. META-ANALYSIS - BIOMECHANICS - ASSESSMENT AND INDICATIONS: A preliminary comparative meta-analysis of the literature studies on ankle and prosthesis biomechanics, reviews validated indications and contra-indications, and details clinical and radiological outcomes assessment protocols.
Sixty-three surgeons (95% AFCP members) answered a professional online survey, by email or regular post: 70% performed total ankle replacement (TAR), 39% of them at least two per year and 16% more than 10 per year, resulting in 317 TARs per year or 50% of the French activity and 312 arthrodeses per year or 17% of the French activity - which gave the survey considerable power. In 2004-2005, 46% of the TARs implanted were AES, 38% Salto and 9% Hintegra.
This study included two series of patients (15 in Brussels and six in Paris) with laboratory gait analysis preoperatively and at 6 months' and 1 year's FU. Following TAR, speed, cadence and strides increased and mean total work approximated normal values. These two independent studies quantified the advantages of TAR over arthrodesis.
This retrospective study had a minimum follow-up of 1 year. Results were not distinguished between the four types of prosthesis (approved by the French Healthcare Agency [HAS]) involved. Inclusion criteria for operators were: AFCP membership, and experience of more than 20 prostheses of a given type. Twelve out of 15 centers responded and undertook to include continuous series. Data were centralized on a dedicated anonymous online site. Five hundred and ninety-two TARs (388 Salto, 173 AES, 22 Hintegra, nine Star) in 555 patients (mean age, 56.4 years; range 17-84 yrs) were included. Indications were post-traumatic arthritis (48%), arthritis associated with laxity (15%), inflammatory arthropathy (20%), primitive arthritis (9%), prosthetic revision (2%), and miscellaneous (5%). Sixty-one percent of operations included associated procedures: 208 Achilles lengthenings, 45 subtalar arthrodeses, nine calcaneal osteotomies and 45 lateral ligament reconstructions. Complications comprised 53 malleolar fractures, and 39 cutaneous and seven infections (9%). At a mean 37 months' FU, 87.5% of patients were satisfied or very satisfied; mean functional score was 82.1/100; radiographic mobility, 23.2 degrees ; and total SF 36 score (on the Short Form Health Survey), 66. X-ray found stable anchorage in 98% of cases, cysts in 15%, and calcification in 4%.
Overall cumulated survivorship was 88% at 71 months: 22 patients underwent arthrodesis (61% satisfied), and 10 implant replacement (50% satisfied).
This multioperator, multi-implant series of 592 patients confirmed literature data. Prospective follow-up of the cohorts managed in these expert centers is essential, in order to make available long-term data.
在法国拥有超过 10 年的经验后,法国足踝外科协会(Association française de chirurgie du pied [AFCP])基于一项多中心研究,对活动式踝关节假体进行了更新。
分析 - 生物力学 - 评估和适应证:对踝关节和假体生物力学的文献研究进行初步比较荟萃分析,回顾验证适应证和禁忌证,并详细介绍临床和影像学评估协议。
63 名外科医生(95%的 AFCP 成员)通过电子邮件或普通邮件回答了专业在线调查:70%进行全踝关节置换(TAR),其中 39%每年至少进行两次,16%每年进行超过 10 次,每年进行 317 次 TAR 或 50%的法国活动量和每年进行 312 次关节融合术或 17%的法国活动量,这使得调查具有相当大的影响力。2004-2005 年,植入的 TAR 中 46%为 AES,38%为 Salto,9%为 Hintegra。
TAR 后的步态分析:这项研究包括两个患者系列(布鲁塞尔 15 例和巴黎 6 例),术前和术后 6 个月和 1 年进行实验室步态分析。TAR 后,速度、步频和步幅增加,平均总工作量接近正常值。这两项独立研究量化了 TAR 相对于关节融合术的优势。
这项回顾性研究的最低随访时间为 1 年。结果未区分涉及的四种类型假体(均已获得法国医疗保健局 [HAS] 的批准)。外科医生的纳入标准为:AFCP 成员和具有给定类型 20 个以上假体的经验。15 个中心中有 12 个做出回应并承诺纳入连续系列。数据集中在一个专用的匿名在线网站上。555 名患者(平均年龄 56.4 岁;范围 17-84 岁)共纳入 592 例 TAR(388 Salto、173 AES、22 Hintegra、9 Star)。适应证为创伤后关节炎(48%)、松弛相关关节炎(15%)、炎症性关节病(20%)、原发性关节炎(9%)、假体翻修(2%)和其他(5%)。61%的手术包括相关手术:208 例跟腱延长术、45 例距下关节融合术、9 例跟骨截骨术和 45 例外侧韧带重建术。并发症包括 53 例距骨骨折和 39 例皮肤和 7 例感染(9%)。在平均 37 个月的随访中,87.5%的患者满意或非常满意;平均功能评分为 82.1/100;放射移动度为 23.2 度;SF-36 总评分(在短格式健康调查中)为 66。X 线发现 98%的病例锚定稳定,15%有囊肿,4%有钙化。
71 个月时总体累积生存率为 88%:22 例患者行关节融合术(61%满意),10 例患者行假体置换术(50%满意)。
这项多外科医生、多植入物的 592 例患者系列证实了文献数据。在这些专家中心管理的队列进行前瞻性随访至关重要,以便提供长期数据。